Dopamine agonists and risk: impulse control disorders in Parkinson's disease - Wikidata - wikimedia - TriplyDB

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

http://www.wikidata.org/entity/Q34992189

about

The functional anatomy of impulse control disorders Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity Impact of Impulse Control Disorders on Sleep-Wake Regulation in Parkinson's Disease Circuit dynamics of adaptive and maladaptive behaviour Risky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adults Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?Cell-Phone Addiction: A Review Dopamine agonists and the suppression of impulsive motor actions in Parkinson disease.Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy The role of dopamine in risk taking: a specific look at Parkinson's disease and gambling Sensitivity and bias in decision-making under risk: evaluating the perception of reward, its probability and value Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.Neuronal correlates of risk-seeking attitudes to anticipated losses in binge drinkers.Maladaptive reward-learning and impulse control disorders in patients with Parkinson's disease: a clinical overview and pathophysiology update Impulse control and related disorders in Parkinson's disease.Disordered gambling: the evolving concept of behavioral addiction Learning Reward Uncertainty in the Basal Ganglia Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease.Trait impulsivity is associated with the risk of falls in Parkinson's disease.Impulse control disorders in Parkinson's disease: recent advances Betting on DBS: Effects of subthalamic nucleus deep brain stimulation on risk taking and decision making in patients with Parkinson's disease An exploration of apathy and impulsivity in Parkinson disease.Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?Impulsivity is Associated with Increased Metabolism in the Fronto-Insular Network in Parkinson's Disease.Effects of acute pramipexole on male rats' preference for gambling-like rewards II.Tuning the Brake While Raising the Stake: Network Dynamics during Sequential Decision-Making Perseveration and choice in Parkinson's disease: the impact of progressive frontostriatal dysfunction on action decisions.No Effect of Subthalamic Deep Brain Stimulation on Intertemporal Decision-Making in Parkinson Patients.Dissociable fronto-striatal effects of dopamine D2 receptor stimulation on cognitive versus motor flexibility.Impulsivity and apathy in Parkinson's disease.Uncertainty about mapping future actions into rewards may underlie performance on multiple measures of impulsivity in behavioral addiction: evidence from Parkinson's disease.Impulse control disorders in Parkinson's disease: the role of personality and cognitive status.Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.Modern treatment in Parkinson's disease, a personal approach.Psychiatric Conditions in Parkinson Disease: A Comparison With Classical Psychiatric Disorders.Dopamine Agonists and Impulse Control Disorders: A Complex Association.Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.Dopamine agonists and pathologic behaviors.How attentional boost interacts with reward: the effect of dopaminergic medications in Parkinson's disease.Effect of Levodopa on Reward and Impulsivity in a Rat Model of Parkinson's Disease.

P2860

Q22252597-83D5D19E-3735-48B0-9CE9-4001C1653F4C Q24616099-7C6B08EF-D3AA-4DED-963B-6DA3FED58E85 Q26776152-0833D0F2-E8BC-49FF-B707-F9C790DFF728 Q27027692-1EBEBC8D-1361-4BA1-86E1-10CCDAF8D2F8 Q27306943-CCE25844-0D18-4EFF-8215-BD33ED4EC88D Q27687503-E26158E7-DCFF-4358-8A7C-1A2C6C5CE41F Q28076660-1ED16E8B-9165-4F72-BB32-68402601B114 Q30419267-AEE0CCA9-DF38-4AFC-B3F7-68F925B5A4E9 Q33603197-8EE66B62-04EF-461E-AA9F-F10AFABC0F03 Q33687660-F644BB86-6B1D-4C7E-B21D-160A8D3EC544 Q34228264-9DBE8C0F-1811-485A-BE76-A35BE3879A20 Q34301607-956702AD-97DF-4A5F-8E3A-905B419DB163 Q34316054-B00F83C3-D516-4EE2-AD46-7876564342FB Q34423280-2FF62116-849B-4936-AAB3-B43E9D4BB9A5 Q34434412-AD975E7B-4D14-4299-8ECE-6A4FF41A40F7 Q34444410-B84AFE5A-5EB5-4DE1-B752-850F43E7BF88 Q34539287-4A933414-E795-4B1C-A072-22017CB1AA07 Q35054558-7C2C95EF-67E6-4597-9A31-D985190D5C46 Q35114732-A0706AFE-D325-4BC7-8F06-1D9924AED942 Q35160241-D3E23841-74BC-497D-8F87-C01A59AA201E Q35696129-40720258-CBD9-4CA8-893C-4F1F0D4C9EAD Q36102120-04A4A69D-A64D-488B-B7A2-CCB2ADC4DF55 Q36143856-6ABB8A07-29B0-487E-B438-75DB0EAF81FE Q36332819-CEC0D074-2692-4EE7-B519-1A5EFD872283 Q36350266-7880419E-FB28-4EF9-94F6-E0C0CD9AD012 Q36889645-C2C277F6-7BC6-4F77-9527-140F1759E394 Q36904284-53A74B91-4F6A-495A-925E-9B6BF3CAD9FC Q36925617-AE3F55E0-CDED-4447-BF27-E84DB06B85CA Q37227887-8B743171-4B3F-4E77-9695-CB6FA55278AC Q37331607-CB1EFF0F-8C22-4740-B912-04CDB4F1A615 Q37604101-3233F1AD-85B8-448A-A947-F74D91D43AFA Q38005346-6BA0B626-7E1E-474C-826D-036E6302FBE0 Q38211499-C1C0DF4F-E913-44B3-B296-2C04A5729163 Q38570529-74F63FA3-FC3F-40A8-9DF4-0C3FE0074CD6 Q38588201-A72A75F8-16B4-4170-B876-E2E90050C71D Q38598331-9561DFE5-5AA8-48F7-91B7-B3A69B554763 Q39311578-5C2E71B2-C2A9-4223-B60F-92B20DA438D4 Q39620073-0BE138FA-9A52-4774-A11D-57BE34BAA39B Q40135602-389D5AD0-746F-40D9-B7E7-366229DC2143 Q41334077-40A5D97F-A99E-49D4-A04F-72532569729F

P2860

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

http://www.wikidata.org/entity/Q34992189

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

@ast

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

@en

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

@nl

type

label

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

@ast

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

@en

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

@nl

prefLabel

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

@ast

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

@en

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

@nl

P1433

Q34992189-7458C3EF-1ED8-4008-B442-DC9C8EA5BE03

P1476

Q34992189-D306AF42-2D56-42CB-8DE4-91E37F8093E7

P2093

Q34992189-2D93BAFB-FAD8-4587-A0A5-8E212FAD6ACC

Q34992189-98177DAA-3E3F-40FE-805C-A89873C5E2CE

Q34992189-9CEF09BF-448E-452B-B55E-C1E57CDEF984

Q34992189-A36DB9DC-79D0-47BF-80F0-E145C941483F

P2860

Q34992189-0A6B4EB6-7EC6-47A3-A38E-5D427973BD97

Q34992189-2C0D3FCE-BCD4-4C60-9608-DA2745521FD1

Q34992189-30B4B077-8407-4EFB-A490-B6395283BAFD

Q34992189-355E04CD-B566-433E-90DE-9FF483187008

Q34992189-531A8318-7FB7-4284-A533-8609188B1A77

Q34992189-5B9E902F-9D56-48E8-ABFA-66DD76492F70

Q34992189-60CDEB79-303B-41B5-848A-9F40E73B57F7

Q34992189-61E10C3D-F7E5-49EC-80CE-842FB96E9CAC

Q34992189-719AA737-7C88-47A6-B492-04BC4BFAB33B

Q34992189-747C023C-EE4F-457D-A3BA-907DC55DC0F3

P304

Q34992189-EAC6706A-BF2E-46C2-93E3-B48F766A3796

P31

Q34992189-7DDD7767-CA68-439C-AB39-D9B8F7B9C384

P356

Q34992189-220541A6-E0BF-4292-86AE-FAD902896147

P407

Q34992189-04460BE6-0565-46CA-B3E7-DFB2C3125CC2

P433

Q34992189-F3F48529-0B61-4790-9403-5C92CA8DB672

P478

Q34992189-B8901C07-EB11-41C5-9840-C29BC86058E3

P50

Q34992189-35BBE366-9296-4CBD-B9C1-8E3F7D54DF1D

Q34992189-6CCA64AA-987E-4520-9836-6D266CFEDD1C

Q34992189-70EE2045-44F0-46C3-97C9-1C3D4A157BF5

Q34992189-FC27FE57-E4EC-4F18-AD67-6E8ADDA7E2F7

P577

Q34992189-B94CE71D-BBE5-4FCA-9873-DBF792F745C9

P5875

Q34992189-BDB38426-3B82-4188-8EB3-8D550A4A0DB0

P698

Q34992189-CD8CD04B-71D9-4264-9472-31207911AB53

P921

Q34992189-36d212df-2641-4057-9cc9-8bd7a4cc3342

Q34992189-47437F3A-5C15-497F-91CE-28AED696BF8F

P932

Q34992189-1FBC65AC-A29F-489B-B46B-B6040075A02E

P356

P1433

P1476

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

@en

P2093

Christina Brezing

http://www.w3.org/2001/XMLSchema#string

Jennifer Gao

http://www.w3.org/2001/XMLSchema#string

Mkael Symmonds

http://www.w3.org/2001/XMLSchema#string

Vindhya Ekanayake

http://www.w3.org/2001/XMLSchema#string

P2860

Thresholding of statistical maps in functional neuroimaging using the false discovery rate

How do you feel--now? The anterior insula and human awareness

Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD.

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors

Discrete coding of reward probability and uncertainty by dopamine neurons.

Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.

Decreased ventral striatal activity with impulse control disorders in Parkinson's disease.

Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

P304

1438-1446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWR080

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 5

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P50

Raymond Joseph Dolan

Hubert H Fernandez

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51150620

http://www.w3.org/2001/XMLSchema#string

P698

21596771

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3097893

http://www.w3.org/2001/XMLSchema#string